Future Science Group Publishing Solutions
Total Page：16
File Type：pdf, Size：1020Kb
Header Future Science Group Publishing Solutions 1 Section Header 2 For more information visit www.future-science-group.com Contents Page Our Journal Portfolio 2 ........................................................................................................................................ Future Medicine At-A-Glance 3 ........................................................................................................................................ Future Science and Newlands Press At-A-Glance 4 ........................................................................................................................................ Publishing Solutions 5 • Open Access 7 • Accelerated Publication 7 • Social Media Sharing 8 • Digital Enhancements 9 • Video Journal of Biomedicine 10 • Plain Language Summaries of Publications 11 • Webinars 11 • Host on an FSG Specialist Website 12 .......................................................................................................................................... PharmaPlatforms 13 .......................................................................................................................................... 1 Our Journal Portfolio Our Journal Portfolio Future Science Group (FSG) is an independent publisher, based in London, with an expanding and diverse group of journals in cutting-edge areas of postgenomic scientific and medical information. FSG houses three imprints; Future Medicine, Future Science and Newlands Press. All journals are peer reviewed and many are also indexed on MEDLINE, Clarivate’s Science Citation Index Expanded and Emerging Sources Citation Index, EMBASE, Chemical Abstracts, DOAJ, PubMed Central and Scopus. We also offer DRM-free perpetual access to a wide variety of eBook collections. ALL PUBLICATIONS ARE: ORIGINAL AND TIMELY Blending commissioned and unsolicited content, including reviews, research and commentaries, to ensure that readers are kept comprehensively up-to-date with the latest advances and techniques in bioscience and clinical practice, whatever their discipline. SUPPORTED BY STRONG EDITORIAL STANDARDS All journals are underpinned by robust double-blind peer review ensuring only articles of the highest quality are published. Authors benefit from a supportive in-house editorial team, taking them from pre-submission enquiries, right through to publication and beyond. VISIBLE AND ACCESSIBLE GLOBALLY To ensure 24/7 access and maximum discoverability, all of our titles are hosted by Atypon on industry-leading websites. 2 For more information visit www.future-science-group.com Future Medicine At-A-Glance FUTURE MEDICINE AT-A-GLANCE Journal MEDLINE- Impact factor Frequency Launch indexed (2018) year Bioelectronics in Medicine No n/a 4 2018 Biomarkers in Medicine Yes 2.268 18 2007 Breast Cancer Management No n/a Rolling 2012 CNS Oncology Yes n/a Rolling 2012 Colorectal Cancer No n/a Rolling 2012 Concussion PMC-indexed n/a Rolling 2015 Epigenomics Yes 4.404 24 2009 Future Cardiology Yes n/a 6 2005 Future Microbiology Yes 2.746 18 2006 Future Neurology No n/a Rolling 2006 Future Oncology Yes 2.279 36 2005 Future Virology No 0.730 12 2006 Hepatic Oncology PMC-indexed n/a Rolling 2014 Immunotherapy Yes 3.028 18 2009 International Journal of Endocrine Oncology No n/a Rolling 2014 International Journal of Hematologic Oncology PMC-indexed n/a Rolling 2012 Journal of 3D Printing in Medicine No n/a 4 2017 Journal of Comparative Effectiveness Research Yes 1.485 18 2012 Lung Cancer Management PMC-indexed n/a Rolling 2012 Melanoma Management PMC-indexed n/a Rolling 2014 Nanomedicine Yes 4.717 30 2006 Neurodegenerative Disease Management Yes n/a 6 2011 Pain Management Yes n/a 6 2011 Personalized Medicine Yes 1.414 6 2004 Pharmacogenomics Yes 2.265 18 2000 Regenerative Medicine Yes 2.383 12 2006 : Open access; PMC: PubMed Central. 3 SectionFuture Science Header and Newlands Press At-A-GlanceFuture Science FUTURE SCIENCE AND NEWLANDS PRESS AT-A-GLANCE Journal MEDLINE- Impact factor Frequency Launch indexed (2018) year Bioanalysis Yes 2.321 24 2009 BioTechniques Yes 1.659 12 1983 Future Drug Discovery No n/a Quarterly 2019 Future Medicinal Chemistry Yes 3.617 24 2009 Future Science OA PMC-indexed n/a Rolling 2015 International Journal of Pharmacokinetics No n/a 4 2016 Pharmaceutical Patent Analyst Yes n/a 6 2012 Therapeutic Delivery Yes n/a 12 2010 : Open access; PMC: PubMed Central. 4 For more information visit www.future-science-group.com Publishing Solutions COMPREHENSIVE COVERAGE Whether you’re looking to publish clinical trial results, describe the design of a new study or provide an in-depth review, our team will support you fully before, during and after publication. We are happy to work with both academic and industry authors, as our goal is to work with the leading specialty experts across all organizations. In addition to offering presubmission advice, we will assist you with journal selection for a broad range of article types, including: ORIGINAL RESEARCH REVIEWS • Pre- and post-registration studies • Narrative reviews • Comparative effectiveness research • Systematic reviews • Observational studies • Unmet medical needs • Clinical trial protocols and • Multidisciplinary approaches to care methodologies • Consensus and treatment • Cost-effectiveness/HEOR studies guidelines • Negative data • Management perspectives • Evidence-based medicine • Therapeutic overviews and real-world data • Drug, device and vaccine • Meta-analyses evaluations • Patient-reported outcomes • Commentaries on key clinical studies 5 Publishing Solutions PUBLISHING SOLUTIONS All FSG journals offer a number of options to ensure each article is published in a timely, accessible manner, engages the reader and reaches a broad audience. 6 For more information visit www.future-science-group.com Institutional Trials Publishing Solutions OPEN ACCESS All FSG journals provide a range of options to make articles freely accessible online. Our subscription journals offer an Open Access option, where articles are made free to read under a CC BY-NC-ND license. Certain articles are excluded from this (such as Drug Evaluation and Device Evaluation articles) and for these articles we offer a Sponsored Access option. We also offer reduced Open Access fees for articles 12 months after publication. Third parties are allowed to support Open Access fees, provided they have been involved with the development of the paper from the outset. FSG also publishes 13 fully Open Access journals, with all articles requiring payment of the Open Access fee on acceptance for publication. Sponsors or third parties wishing to make an article free to download from our website, for use on a commercial basis, can provide access by paying the appropriate Sponsored Access fee. More information on the Sponsored Access option is available upon request. ACCELERATED PUBLICATION umission Our typical publication times from submission to acceptance are ~16 Wee PEER weeks as standard (subject to peer REVIEW review). However, if you require earlier publication, or by a specific date, you can Wee publish in as little as 6 weeks through our Accelerated Publication service. Wee Accelerated Publication could help you stay ahead of the field, or allow you to get some AUTHOR REVISION Wee vital content out to coincide with a conference or meeting. It will maximize the impact of your scientific Wee PRODUCTION endeavour, ensuring swifter access to your latest findings. A fee per published page AUTHOR APPROVAL nine applies, and publication is, of course, still uication subject to independent peer review. 7 Publishing Solutions SOCIAL MEDIA REACH It has been said that physicians globally spend at least 1.5 hours online per day conducting research, with at least half of that on social media. Therefore sharing the news that an article has been published via social media is a great way to keep interested readers informed about your work. All FSG journals are active on social media, including Twitter, Facebook and LinkedIn, sharing articles when published. Posts are tailored to ensure the greatest discoverability of articles, with images and videos used as well as #hashtags and @mentions where relevant. All articles also include sharing links at the top of the page, making it easy for authors and readers alike to create posts for articles. All conversations surrounding articles are measured and can be viewed via the Altmetric score displayed on the article homepage. We can also offer extended reach via social media, offering options to increase the audience for articles and reach a specific reader demographic. Details of this option are available upon request. 8 Publishing Solutions Institutional Trials LBA ey trend in LA DIGITAL ENHANCEMENTS In hat area of application do you ue LA? hat do you invetiate uin LA? inica iscover rug) 73% VIDEOS AND VIDEO ABSTRACTS 57% 40% 69% (target or iomarer) armaceutica Forensic Time-constrained physicians are now spending more 53% 7% afet assessment 47% and more time watching video content for professional DMPK rug) 30% ter recision meicine 18% purposes. Videos enhance publications by allowing authors to 7% explain their work in a way that the print article or a static figure cannot. All our journals can feature a range of videos, including hat do you ue LA for hat molecule do you analyze uin LA? Terapeutic proteins video abstracts, mechanism of action videos, videos of procedures, and more. onocona antioies rotein iomarers arge ma moecue anasis ot moecue nogenous anates